Holm-Jorgensen Rasmus 4
4 · Acrivon Therapeutics, Inc. · Filed Feb 16, 2024
Insider Transaction Report
Form 4
Holm-Jorgensen Rasmus
Chief Financial Officer
Transactions
- Tax Payment
Common Stock
2024-02-14$3.40/sh−434$1,476→ 27,626 total
Footnotes (1)
- [F1]Shares withheld by the Issuer to satisfy the mandatory tax withholding requirement upon vesting of restricted stock units.